4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-25-000004
Chairperson & CEO sold 8,000 shares at an average $397.97 ($3,183,777)
- Chairperson & CEO acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,000 | $120.26 | $481,040 | 4,130 | D |
| 2025-09-10 | Sale : show line 2 in the form 10b5-1 | −2,000 | $398.11 | $796,220 | 2,130 | D |
| 2025-09-10 | Sale : show line 3 in the form 10b5-1 | −2,000 | $399.33 | $798,653 | 130 | D |
| 2025-09-11 | Exercise or conversion : show line 4 in the form 10b5-1 | +4,000 | $120.26 | $481,040 | 4,130 | D |
| 2025-09-11 | Sale : show line 5 in the form 10b5-1 | −4,000 | $397.23 | $1,588,904 | 130 | D |
| Open-market sales · 8,000 sh · avg $397.97 · $3,183,777 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-09-10 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option | −4,000 | $120.26 | 2026-03-15 | 4,000 | 282,000 | D |
| 2025-09-11 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option | −4,000 | $120.26 | 2026-03-15 | 4,000 | 278,000 | D |
Loading xslF345X05/primarydocument.xml…